Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis

Characteristics

N = 624

Age, years, mean (SD)

47.6 (13.8)

Gender, n (%)

 

Women

408 (65.4)

Ethnicity, n (%)

 

Caucasian

611 (97.9)

Marital status, n (%)

 

Married

379 (60.7)

Single

132 (21.1)

Other1

113 (18.1)

Education, n (%)

 

Illiterate

12 (1.9)

Basic school education

252 (40.4)

High school/higher education

316 (50.6)

Employment status, n (%)

 

Active

264 (42.3)

Not working (unemployed or sick leave)

148 (23.7)

Other2

212 (34.0)

Patients with medical comorbidity, n (%)

339 (54.3)

Family psychiatric history, n (%)

221 (35.4)

Number of previous episodes, mean (SD)

2.6 (2.5)

Patients with 1st episode, n (%)

280 (44.9)

Age at first episode of depression, mean (SD)

40.5 (14.0)

Current depressive episode:

 

Length, mean weeks (SD)

13.9 (23.5)

Chronicity ≥2 years, n (%)

38 (6.1)

HAMD-17 total score, mean (SD)

24.6 (5.7)

Residual symptoms, mean (SD)

 

Core mood3

8.7 (2.3)

Insomnia4

3.9 (1.4)

Anxiety5

6.2 (2.2)

Somatic6

1.1 (0.6)

VAS-overall pain, total score (mean)

41.4 (28.2)

Monotherapy, n (%)

550 (88.1)

SSRI

145 (26.4)

SNRI

387 (70.3)

Tricyclic antidepressants

6 (1.1)

Others

12 (2.2)

Combination of antidepressants, n (%)

74 (11.9)

  1. MDD = Major depressive disorder; SSRI = Selective serotonin reuptake inhibitor; SNRI = Serotonin-norepinephrine reuptake inhibitor; SD = Standard deviation; VAS = Visual Analog Scale; 1Widowed, separated, divorced and other; 2Student, housekeeping, retired, disabled worker; 3depressed mood [Item 1], guilt [Item 2], suicide [Item 3], and anergia/anhedonia [Item 7] of the HAMD-17; 4early [Item 4], middle [Item 5], and late insomnia [Item 6] of the HAMD-17; 5agitation [Item 9], psychic anxiety [Item 10], somatic anxiety [Item 11], and hypochondriasis [Item 15] of the HAMD-17; 6item 13 of the HAMD-17.